Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on Growth Update - Case Based Approach to short stature
A case-based approach to managing short stature provides a comprehensive framework for understanding and addressing the condition in pediatric patients. Short stature, defined as a height significantly below the average for a child's age and sex, can be caused by a variety of genetic, hormonal, and environmental factors. This approach involves detailed case evaluations to identify the underlying causes and determine the most appropriate interventions.
The first step in a case-based approach is a thorough evaluation of the patient’s medical history, growth patterns, and physical examination findings. Key assessments include growth charts, familial height patterns, and screening for chronic illnesses or nutritional deficiencies. Hormonal evaluations and genetic testing may also be necessary to pinpoint specific causes, such as growth hormone deficiencies or genetic syndromes.
Tailored treatment plans ensure that each patient receives the most effective and targeted intervention based on their unique condition and needs.
Therefore, get an overall knowledge of growth update - case based approach to short stature
See More Webinars @ Hidoc Webinars
1.
Parkinson patient's gait is restored by a spinal cord stimulator.
2.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
3.
Next Day Mood Is Affected by Ability to Recover From Work.
4.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
5.
Children with cancer experience much less pain at home when using a pain monitoring app.
1.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
2.
Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology
3.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
4.
The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects
5.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation